Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.89 |
| ▸ | CHAT | P28329 | 2/20 | 0.85 |
| ▸ | EP300 | Q09472 | 3/20 | 0.84 |
| ▸ | AURKA | O14965 | 2/20 | 0.84 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.84 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.84 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21874989 | 1.00 | NAA50 (0.89) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL28097736 | 1.00 | NAA50 (0.89) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL25996812 | 1.00 | NAA50 (0.89) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL59684 | 1.00 | NAA50 (0.89) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL120458 | 1.00 | NAA50 (0.89) | NAA50CHATEP300AURKAKAT5 | |
| Lithium SCHEMBL18249414 | 0.99 | NAA50 (0.88) | NAA50CHATEP300AURKAKAT5 | |
| Lithium SCHEMBL29390807 | 0.99 | NAA50 (0.88) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL28324180 | 0.98 | NAA50 (0.86) | NAA50CHATEP300AURKAKAT5 | |
| Isobutyraldehyde SCHEMBL28444156 | 0.97 | NAA50 (0.84) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL28487648 | 0.97 | NAA50 (0.84) | NAA50CHATEP300AURKAKAT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150218601-A1 | MICROBIOLOGICAL PRODUCTION OF 3-HYDROXYISOBUTYRIC ACID | EVONIK ROEHM GMBH (DE) | 2015-08-06 | — | — | US | disclosed |